Ok. Off ignore. Too many fractured threads.
Mgt picked the medical/scientific advisory group, who structured the trials.
But, the raw results will dictate where we go from here.
Fail DM PH2 and we’ll drop back, dunno how far.
Succeed DM PH2 and we’ll push through past where we are today. Much higher...
Its then up to mgt to negotiate the best deal going fwd.
Valuation post positive results, page-119
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $209.1M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 36.5¢ | $579.4K | 1.548M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 91570 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 7922 | 2 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |